Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments

About this update from Tripadvisor, Inc.

[{"type":"list","items":[{"val":[{"type":"text","content":"Three new license agreements signed and two research shipments completed in March 2026, spanning institutions in Australia, the United Kingdom, and Canada","length":154,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":154,"olType":false},{"type":"text","content":"Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that Filament Health Corp. ("Filament") signed three new license agreements and completed two research shipments during March 2026, further expanding the global clinical network for PEX010, Filament's patented botanical psilocybin drug candidate.","length":442,"tagName":"p"},{"type":"text","content":"Red Light recently announced a definitive arrangement agreement to acquire Filament Health Corp., including its portfolio of 76 issued patents across 15 patent families and its lead drug candidate, PEX010. On March 23, 2026, Filament obtained an interim order from the Supreme Court of British Columbia in connection with the proposed arrangement. The transaction remains subject to Filament shareholder approval, final court approval, and other customary closing conditions.","length":475,"tagName":"p"},{"type":"text","content":"New License Agreements:","length":23,"tagName":"p"},{"type":"text","content":"Recently, Filament entered into license agreements with the following institutions for clinical research involving PEX010:","length":122,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"University of Melbourne (Australia) - for a study titled Psilocybin-assisted physiotherapy for refractory Functional Neurological Disorder","length":138,"tagName":"p"}]},{"val":[{"type":"text","content":"Imperial College London (United Kingdom) - for a study titled PsiloGambling: Psilocybin in Gambling Disorder: Multimodal brain and physiological biomarkers of action","length":165,"tagName":"p"}]},{"val":[{"type":"text","content":"University of Calgary (Canada) - for a study titled Psilocybin-assisted therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence","length":156,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":459,"olType":false},{"type":"text","content":"Recent Shipments:","length":17...

More updates from Tripadvisor, Inc.